TrialJournal of comparative effectiveness research2024

A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy.

Jeff Schein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.